Basson M Albert, van Ravenswaaij-Arts Conny
King's College London, Department of Craniofacial Development and Stem Cell Biology and MRC Centre for Developmental Neurobiology, Floor 27, Guy's Hospital Tower Wing, London, SE1 9RT, UK.
University of Groningen, University Medical Center Groningen, Department of Genetics, PO Box 30.001, 9700RB Groningen, The Netherlands.
Trends Genet. 2015 Oct;31(10):600-611. doi: 10.1016/j.tig.2015.05.009. Epub 2015 Sep 24.
CHARGE syndrome is a rare genetic syndrome characterised by a unique combination of multiple organ anomalies. Dominant loss-of-function mutations in the gene encoding chromodomain helicase DNA binding protein 7 (CHD7), which is an ATP-dependent chromatin remodeller, have been identified as the cause of CHARGE syndrome. Here, we review recent work aimed at understanding the mechanism of CHD7 function in normal and pathological states, highlighting results from biochemical and in vivo studies. The emerging picture from this work suggests that the mechanisms by which CHD7 fine-tunes gene expression are context specific, consistent with the pleiotropic nature of CHARGE syndrome.
CHARGE综合征是一种罕见的遗传综合征,其特征是多种器官异常的独特组合。编码染色质结构域解旋酶DNA结合蛋白7(CHD7)的基因发生显性功能丧失突变,CHD7是一种ATP依赖的染色质重塑因子,已被确定为CHARGE综合征的病因。在这里,我们综述了最近旨在了解CHD7在正常和病理状态下功能机制的研究工作,重点介绍了生化和体内研究的结果。这项工作中呈现出的新情况表明,CHD7微调基因表达的机制具有上下文特异性,这与CHARGE综合征的多效性本质是一致的。